1082373-80-5

Basic information

• Product Name: 7-HydroxyMethyl-spiro[3.5]nonane
• Synonyms: 7-HydroxyMethyl-spiro[3.5]nonane;Spiro[3.5]nonane-7-methanol
• CAS NO: 1082373-80-5
• Molecular Formula: C₁₀H₁₈O
• Molecular Weight: 154.24932
• Mol File: 1082373-80-5.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 7-HydroxyMethyl-spiro[3.5]nonane(CAS DataBase Reference)
• NIST Chemistry Reference: 7-HydroxyMethyl-spiro[3.5]nonane(1082373-80-5)
• EPA Substance Registry System: 7-HydroxyMethyl-spiro[3.5]nonane(1082373-80-5)

Safety Data

• Hazardous Substances Data: 1082373-80-5(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
7-HydroxyMethyl-spiro[3.5]nonane is used as a building block in organic synthesis for its unique spiro arrangement, which allows for the creation of complex molecules with diverse applications.
Used in Pharmaceutical Research:
In pharmaceutical research, 7-HydroxyMethyl-spiro[3.5]nonane is utilized as a key intermediate in the development of novel drugs. Its structural features can be exploited to design and synthesize new pharmaceutical compounds with potential therapeutic benefits.
Used in Materials Science:
7-HydroxyMethyl-spiro[3.5]nonane is employed in materials science as a precursor for the synthesis of advanced materials. Its distinctive properties can contribute to the development of new polymers and other materials with unique characteristics and applications.
As research on 7-HydroxyMethyl-spiro[3.5]nonane continues, it is expected that additional applications and benefits will be discovered, further expanding its utility across various industries.

Upstream product

• 1086399-15-6 spiro[3.5]nonane-7-carboxylic acid 

Downstream Products

• 1180557-41-8 C₁₇H₂₄O₃S 

Relevant articles and documents

Aliphatic cycloalkyl derivatives Preparation method, pharmaceutical composition and application thereof

The invention discloses an aliphatic cycloalkyl derivative, a preparation method thereof, a pharmaceutical composition and an application thereof. The invention provides an aliphatic cycloalkyl derivative represented by a formula I or a pharmaceutically a

Overcoming hERG issues for brain-penetrating cathepsin S inhibitors: 2-Cyanopyrimidines. Part 2

We describe here orally active and brain-penetrant cathepsin S selective inhibitors, which are virtually devoid of hERG K+ channel affinity, yet exhibit nanomolar potency against cathepsin S and over 100-fold selectivity to cathepsin L. The new

COMPOUNDS AND COMPOSITIONS USEFUL AS CATHEPSIN S INHIBITORS

The present invention relates to the use of a 2-cyanopyrimidine compound of the formula (I), wherein R1, R2, R3 and X are as defined in the specification and in the claims, in free form or in salt form, and , where possible, in tautomeric form, as an inhibitor of the activity of cathepsin S.